| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 13, 2024 | Feb 21, 2024 | NewAmsterdam Pharma Co N.V. | Director | Buy | 95.0 | +5,000 | 25.15% | ✗ | $95K |
| Jul 1, 2013 | Jul 1, 2013 | Esperion Therapeutics, Inc. | Director | Buy | 90.0 | +14,214 | 7.06% | ✗ | $199K |